Exposure Therapy Combined With Cortical Interventions for CRPS-II
ETHICS
Leaving the Wheelchair Behind - Treating CRPS-II With Exposure Therapy Combined With Cortical Interventions: a Series of Case Reports
1 other identifier
interventional
4
1 country
1
Brief Summary
Consecutive patients with long-standing complex regional pain syndrome II in a lower limb are treated with graded exposure therapy in vivo in combination with methods targeting cortical reorganisation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Sep 2012
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2015
CompletedFirst Submitted
Initial submission to the registry
March 28, 2017
CompletedFirst Posted
Study publicly available on registry
June 2, 2017
CompletedJune 2, 2017
May 1, 2017
2.7 years
March 28, 2017
May 30, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Photograph series of daily activities, PHODA
A measure of avoidance of activities - the subject reports level of hesitation in performing a number of everyday activities on a 0-100 rating scale.
12 weeks
Secondary Outcomes (1)
The Tampa Scale of Kinesiophobia - Short Form, TSK-SF
12 weeks
Study Arms (1)
Exposure therapy
EXPERIMENTALGraded exposure therapy in vivo in combination with methods targeting cortical reorganisation.
Interventions
Daily training at an in-patient ward during four plus four weeks, separated by a home training period of 6-8 weeks.
Eligibility Criteria
You may qualify if:
- Complex regional pain syndrome II
You may not qualify if:
- Severe psychiatric disorder drug abuse
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Uppsala Universitylead
- Folksamcollaborator
Study Sites (1)
Uppsala university hospital
Uppsala, 751 85, Sweden
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Torsten Gordh, PhD
Uppsala University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 28, 2017
First Posted
June 2, 2017
Study Start
September 1, 2012
Primary Completion
June 1, 2015
Study Completion
June 1, 2015
Last Updated
June 2, 2017
Record last verified: 2017-05
Data Sharing
- IPD Sharing
- Will not share